Dow Up0.11% Nasdaq Up0.50%

Echo Therapeutics, Inc. (ECTE)

-NasdaqCM
1.86 Up 0.01(0.54%) Aug 29, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Sep 30, 2013Jun 30, 2013
Total Revenue 19   19   23   23  
Cost of Revenue -   -   -   -  
Gross Profit 19   19   23   23  
Operating Expenses
Research Development1,998  1,150  2,756  4,019  
Selling General and Administrative1,936  1,539  2,192  2,098  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,915) (2,670) (4,926) (6,095)
Income from Continuing Operations
Total Other Income/Expenses Net395  140  (69)2,996  
Earnings Before Interest And Taxes(3,520)(2,530)(4,995)(3,099)
Interest Expense244  243  242  242  
Income Before Tax(3,764)(2,773)(5,237)(3,341)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(3,764)(2,773)(5,237)(3,341)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (3,764) (2,773) (5,237) (3,341)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (3,764) (2,773) (5,237) (3,341)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.